We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Struggling Teva Pharmaceutical Plans To Raise $5B In Debt

Law360, New York (January 30, 2018, 5:16 PM EST) -- Generic pharmaceutical giant Teva Pharmaceutical Industries Limited, which is implementing a major cost-cutting campaign intended turn around its business performance, plans to raise $5 billion in new debt, according to a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.